Skip to main content

Table 2 Association between BP1 mRNA expression and clinicopathological data

From: Correlation of expression of BP1, a homeobox gene, with estrogen receptor status in breast cancer

 

BP1 mRNA

 

Factors

Negative

Positive

P

Age

  

1.00

   Premenopausal

2 (17%)

10 (83%)

 

(<50 years)

   

   Postmenopausal

7 (21%)

26 (79%)

 

(≥ 50 years)

   

Tumor size

  

1.00

   <2.0 cm

1 (17%)

5 (83%)

 

   ≥ 2.0 cm

7 (19%)

30 (81%)

 

Lymph node metastasis

  

1.00

   Negative

4 (20%)

16 (80%)

 

   Positive

4 (18%)

18 (82%)

 

Histologic grade

  

0.29

   I

1 (20%)

4 (80%)

 

   II

4 (27%)

11 (73%)

 

   III

2 (9%)

20 (91%)

 

ER status

  

0.03

   Negative

0 (0%)

18 (100%)

 

   Positive

7 (27%)

19 (73%)

 

PR status

  

0.02

   Negative

1 (4.0%)

24 (96%)

 

   Positive

6 (33%)

12 (67%)

 

Race

  

0.04

   Caucasian

6 (43%)

8 (57%)

 

   African American

3 (11%)

25 (89%)

 
  1. ER, estrogen receptor; PR, progesterone receptor. Data were unavailable or indeterminate for parameters as follows: age (one tumor), tumor size (three tumors), lymph node metastasis (four tumors), histologic grade (four tumors), ER status (two tumors), PR status (three tumors), and race (four tumors).
Back to article page

Breast Cancer Research

ISSN: 1465-542X

Contact us